P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.
Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, Shao L, Yang R, Lin Z, Wu X, Huang TY, Wang Z, Zhang YW, Xu H, Zhao Y.
Zhang D, et al. Among authors: ming c.
Neuron. 2024 Mar 12:S0896-6273(24)00127-2. doi: 10.1016/j.neuron.2024.02.017. Online ahead of print.
Neuron. 2024.
PMID: 38513667